Immunogenicity
Mostrando 25-36 de 1219 artigos, teses e dissertações.
-
25. A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
This randomised, double-blind, multicentre study with children nine-23 months old evaluated the immunogenicity of yellow fever (YF) vaccines prepared with substrains 17DD and 17D-213/77. YF antibodies were tittered before and 30 or more days after vaccination. Seropositivity and seroconversion were analysed according to the maternal serological status and th
Mem. Inst. Oswaldo Cruz. Publicado em: 2015-09
-
26. Influenza vaccines for preventing cardiovascular disease
ABSTRACTBACKGROUND: This is an update of the original review published in 2008. The risk of adverse cardiovascular outcomes is increased with influenza-like infection, and vaccination against influenza may improve cardiovascular outcomes.OBJECTIVES: To assess the potential benefits of influenza vaccination for primary and secondary prevention of cardiovascul
Sao Paulo Med. J.. Publicado em: 2015-08
-
27. Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
A non-controlled longitudinal study was conducted to evaluate the combined vaccine against measles, mumps and rubella (MMR) immunogenicity in 150 children vaccinated in the routine of three health units in the city of Rio de Janeiro, Brazil, 2008-2009, without other vaccines administered during the period from 30 days before to 30 days after vaccination. A p
Mem. Inst. Oswaldo Cruz. Publicado em: 07/05/2014
-
28. Interleukin-12 gene adjuvant increases the immunogenicity of virus-like particles of human papillomavirus type 16 regional variant strain
Objectives: To analyze the immunogenicity of virus-like particles (VLP) of human papillomavirus type 16 (HPV16) isolated in East China and the adjuvant potential of interleukin-12 (IL-12). Methods: The variant HPV16 L1VLP expressed in sf9 insect cells were purified with cesium chloride gradient centrifugation. BALB/c mice were vaccinated with VLP (L1N), V
Braz J Infect Dis. Publicado em: 2014-01
-
29. Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax
The PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were found in sera of falciparum malaria patients from Rondônia,
Mem. Inst. Oswaldo Cruz. Publicado em: 2013-02
-
30. Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy
OBJECTIVE: To assess the potential acute effects regarding the immunogenicity and safety of non-adjuvanted influenza A H1N1/2009 vaccine in patients with mixed connective tissue disease and healthy controls. METHODS: Sixty-nine mixed connective tissue disease patients that were confirmed by Kasukawa's classification criteria and 69 age- and gender-matched co
Clinics. Publicado em: 2013
-
31. Imunogenicidade e segurança da vacina contra influenza A H1N1/2009 em pacientes com artrite idiopática juvenil / Immunogenicity and safety of the influenza A H1H1/2009 vaccine in juvenile idiopathic arthritis patients
Introdução: A pandemia de gripe A H1N1 em junho de 2009 resultou em elevadas taxas de hospitalização entre pacientes imunodeprimidos, incluindo pacientes com artrite idiopática juvenil (AIJ). Embora a vacinação seja uma medida eficaz contra complicações da gripe pandêmica, não há estudos na literatura sobre seus efeitos na AIJ. Objetivos: Avaliar
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 06/11/2012
-
32. Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
Human cytomegalovirus glycoprotein B (gB) represents a target for diagnosis and treatment in view of the role it plays in virus entry and spread. Nevertheless, to our knowledge, rare detection of a gB antigen has been reported in transplant patients and limited information is available about diagnostic gB monoclonal antibodies (mAbs). Our aim was to develop
Brazilian Journal of Medical and Biological Research. Publicado em: 2012-07
-
33. Assessment of immunity against avian colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers
Colibacillosis is an important disease in the poultry industry which causes serious economic damages. As it is suggested that vaccination is one of the means to control colibacillosis, we tried to investigate the vaccine potential of a ΔaroA derivative of an O78:K80 avian pathogenic Escherichia coli containing increased serum survival gene. 490 chicks were
Brazilian Journal of Microbiology. Publicado em: 2012-03
-
34. Estudo da imunogenicidade de esquemas alternativos de vacinação contra influenza em receptores de transplante de células tronco hematopoiéticas / Study of the immunogenicity of alternative schedules of influenza vaccination in hematopoietic stem cell transplant recipients
INTRODUÇÃO: Influenza é uma doença potencialmente grave após o transplante de células tronco hematopoiéticas (TCTH). A vacinação é a principal estratégia profilática, mas a resposta imune é menor do que em indivíduos saudáveis. Em geral os pacientes não respondem a vacinação nos primeiros seis meses após transplante, o que torna o período
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 08/11/2011
-
35. TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium
Recently, we described the improved immunogenicity of new malaria vaccine candidates based on the expression of fusion proteins containing immunodominant epitopes of merozoites and Salmonella enterica serovar Typhimurium flagellin (FliC) protein as an innate immune agonist. Here, we tested whether a similar strategy, based on an immunodominant B-cell epitope
Memórias do Instituto Oswaldo Cruz. Publicado em: 2011-08
-
36. Synergism/complementarity of recombinant adenoviral vectors and other vaccination platforms during induction of protective immunity against malaria
The lack of immunogenicity of most malaria antigens and the complex immune responses required for achieving protective immunity against this infectious disease have traditionally hampered the development of an efficient human malaria vaccine. The current boom in development of recombinant viral vectors and their use in prime-boost protocols that result in en
Memórias do Instituto Oswaldo Cruz. Publicado em: 2011-08